Skyscape Web Viewer : Phillips's Manual of I.V. Therapeutics: Evidence-Based Practice for Infusion Therapy : Main Index

View All
Continuous IV infusion
Continuous Quality Improvement (CQI) accreditation benchmarking Continuous Quality Improvement Continuous Quality Improvement National Patient Safety Goals National Patient Safety Goals patient experience data publicly reported outcomes value-based purchasing (VBP)
Continuous SC infusion (CSI) IV Medication Administration Other Infusion Medication Routes Reference Reference
Cortisol
COVID-19 pandemic CLABSI generally home care home care monoclonal antibody treatment monoclonal antibody treatment REGEN-COV transmission vaccination vaccination
ASPEN
Assessment Clinical Competency Nursing Process Related to Infusion Therapy
Atrial natriuretic peptide (ANP)
Audit and feedback Continuous Quality Improvement Continuous Quality Improvement
Authorized agent-controlled analgesia (AACA) IV Medication Administration IV Medication Administration
Autoimmune disease
Autologous blood recovery
Autologous donation Blood Donor Collection Methods Blood Donor Collection Methods
Azotemia
Babesia
Backcheck valve Administration Sets Administration Sets Administration Sets
Baclofen
Bacteremia
Bacterial phlebitis Local Complications Local Complications
Balanced electrolyte solutions Characteristics/Contents of Available IV Fluids Crystalloid Solutions Crystalloid Solutions Crystalloid Solutions
CQI
CR-BSI
Creatinine
Creatinine/height index
Creutzfeldt-Jakob disease (CJD)
Crossmatch
CRPS
CRPS II
Cryoprecipitated antihemophilic (AHF) Blood Component Therapy Summary of Common Blood Components
Crystalloid IV fluids